Status:
COMPLETED
A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer
Lead Sponsor:
Tianjin Chest Hospital
Collaborating Sponsors:
LinkDoc Technology (Beijing) Co. Ltd.
Conditions:
Non-small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
A study to compare patient survivals in the N2 patients with non-small cell lung cancer in the subgroups of lymph skip metastases and non-skip metastases
Detailed Description
A multi-centre real-world non-interventional observational study to retrospectively collect the study data on patient demographic/tumor biological characteristics and clinical treatments to compare pa...
Eligibility Criteria
Inclusion
- Patients with surgeries from 2014 to 2017;
- Pathologically diagnosed patients with non-small cell lung cancer;
- Age \> 18 years old;
- Patients with chest surgeries before hospitalization;
- Patients with N2 lymph nodes (+) after surgeries who received lymphadenectomy (Group 10 and 11 lymph nodes);
Exclusion
- \- Patients with radiotherapies, chemotherapies and biological therapies for tumors
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2018
Estimated Enrollment :
2653 Patients enrolled
Trial Details
Trial ID
NCT03429192
Start Date
December 1 2017
End Date
March 30 2018
Last Update
May 21 2018
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China, 100029
2
China People's Liberation Army Hospital
Beijing, Beijing Municipality, China, 100853
3
Henan Cancer Hospital
Zhengzhou, Henan, China, 450008
4
Tongji Hospital Affiliated to Huaxi Technology University
Wuhan, Hubei, China, 430030